(Q38170010)

30 August 2017

title

New insight into neurodegeneration: the role of proteomics (English)

1 reference

30 August 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Simon G. Møller

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Ramavati Pal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jan Petter Larsen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

10 December 2013

1 reference

30 August 2017

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1181-1199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24323427%20AND%20SRC:MED&resulttype=core&format=json

Motor neuron involvement in multisystem proteinopathy: implications for ALS

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

In search of genes involved in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The roles of intracellular protein-degradation pathways in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Genes and the environment in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Genetic and environmental factors in cancer and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Toxic proteins in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Differentiation of neuronal cells from NIH/3T3 fibroblasts under defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The prevalence and causes of dementia in people under the age of 65 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Genetic aspects of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Genetics of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Trinucleotide repeat length and progression of illness in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Protein aggregation and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The spectrum of lower motor neuron syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Mass spectrometry-based proteomics: existing capabilities and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Functional genomics and proteomics as a foundation for systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Dissecting protein function and signaling using protein microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The protein kinase complement of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Functional proteomics to dissect tyrosine kinase signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The proteomics big challenge for biomarkers and new drug-targets discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Eponemycin analogues: syntheses and use as probes of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Biomarker discovery: proteome fractionation and separation in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Redox proteomics: identification of oxidatively modified proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Redox proteomics: basic principles and future perspectives for the detection of protein oxidation in plants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Systematic and quantitative assessment of the ubiquitin-modified proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Building ubiquitin chains: E2 enzymes at work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

A proteomics approach to understanding protein ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomics-driven progress in neurodegeneration research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic identification of novel proteins associated with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Amyloid fibrils from the viewpoint of protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The importance of neuritic plaques and tangles to the development and evolution of AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Role of axonal transport in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Automated ultra-high-pressure multidimensional protein identification technology (UHP-MudPIT) for improved peptide identification of proteomic samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Applied proteomics: mitochondrial proteins and effect on function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic identification of novel proteins in cortical lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Synucleinopathies: clinical and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Alpha-synuclein and Parkinson's disease: a proteomic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomics in animal models of Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Monomeric synucleins generate membrane curvature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Treatment of mice with methamphetamine produces cell loss in the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Targeting proteases: successes, failures and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

DJ-1 has a role in antioxidative stress to prevent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Identification of potential CSF biomarkers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Unraveling the pathogenesis of Parkinson's disease--the contribution of monogenic forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Genetics of Parkinson's disease and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

LRRK2 in Parkinson's disease: genetic and clinical studies from patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Kinase inhibitors as potential therapeutics for acute and chronic neurodegenerative conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Update on genetics of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Akt1 regulates a JNK scaffold during excitotoxic apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Genotype and phenotype in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Parkinson's disease subtypes: lost in translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Androgen receptor mutation in Kennedy's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Prion diseases of humans and animals: their causes and molecular basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Plasma biomarkers of brain atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

A proteomic approach in the study of an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Influence of Huntington's disease on the human and mouse proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomics of polyglutamine aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Mass spectrometric identification of novel posttranslational modification sites in Huntingtin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

A quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8590-8

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

12 December 2020

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

1 reference

12 December 2020

Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains

1 reference

12 December 2020

A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein.

1 reference

12 December 2020

Multiple System Atrophy

1 reference

12 December 2020

Dentatorubral-pallidoluysian atrophy (DRPLA): clinical features and molecular genetics.

1 reference

12 December 2020

Dentatorubral-pallidoluysian atrophy (DRPLA). Molecular basis for wide clinical features of DRPLA

1 reference

12 December 2020

[Hereditary ataxias and paraplegias: a clinicogenetic review]

1 reference

12 December 2020

The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease

1 reference

12 December 2020

Shaking the genome: new studies reveal genetic risk for Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease

1 reference

12 December 2020

Replication of GWAS Associations for GAK and MAPT in Parkinson's Disease

1 reference

12 December 2020

Clinical Subtypes of Frontotemporal Dementia

1 reference

12 December 2020

DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism

1 reference

12 December 2020

A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics

1 reference

12 December 2020

Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection

1 reference

12 December 2020

Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach

1 reference

12 December 2020

2-D or not 2-D--is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting

1 reference

12 December 2020

Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.

1 reference

12 December 2020

Proteomics from the clinical perspective: many hopes and much debate

1 reference

12 December 2020

Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity

1 reference

12 December 2020

Amyotrophic lateral sclerosis

1 reference

12 December 2020

Phospholipase A2 and its role in brain tissue.

1 reference

12 December 2020

Etiology and pathogenesis of Parkinson's disease

1 reference

12 December 2020

Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease

1 reference

12 December 2020

Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry

1 reference

12 December 2020

alpha-Synuclein is phosphorylated in synucleinopathy lesions

1 reference

12 December 2020

Genetics of Parkinson's disease

1 reference

12 December 2020

Electrospray ionisation mass spectrometry: principles and clinical applications

1 reference

12 December 2020

Plasma proteomics for the identification of Alzheimer disease

1 reference

12 December 2020

PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy

1 reference

12 December 2020

1 reference

12 December 2020

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size

1 reference

12 December 2020

Subcellular proteomics in neuroscience

1 reference

12 December 2020

Proteome analysis of the sera from Chinese Parkinson's disease patients

1 reference

12 December 2020

Proteomic analysis of glutathione transferases from the liver fluke parasite, Fasciola hepatica

1 reference

12 December 2020

Herpes simplex virus type 1 in Alzheimer's disease: the enemy within

1 reference

12 December 2020